1. Home
  2. CRBP vs OGI Comparison

CRBP vs OGI Comparison

Compare CRBP & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CRBP

Corbus Pharmaceuticals Holdings Inc.

N/A

Current Price

$11.31

Market Cap

190.3M

Sector

Health Care

ML Signal

N/A

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

N/A

Current Price

$1.19

Market Cap

171.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRBP
OGI
Founded
2009
2013
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.3M
171.3M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
CRBP
OGI
Price
$11.31
$1.19
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$45.50
N/A
AVG Volume (30 Days)
516.3K
999.2K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,822,272.00
N/A
Revenue This Year
N/A
$20.10
Revenue Next Year
$116.00
$13.92
P/E Ratio
N/A
$13.91
Revenue Growth
97.62
N/A
52 Week Low
$7.12
$0.85
52 Week High
$20.56
$2.24

Technical Indicators

Market Signals
Indicator
CRBP
OGI
Relative Strength Index (RSI) 66.21 54.30
Support Level $7.62 $1.18
Resistance Level $11.64 $1.21
Average True Range (ATR) 0.60 0.05
MACD 0.07 -0.01
Stochastic Oscillator 83.08 0.07

Price Performance

Historical Comparison
CRBP
OGI

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Share on Social Networks: